Profound hypocalcaemia after zoledronic acid treatment

Huong V Nguyen,* Katherine B Ingram,^† Jonathan Beilin^‡

Correspondence: Huong.Nguyen@health.wa.gov.au

1. Major P. The use of zoledronic acid, a novel, highly potent bisphosphonate for the treatment of hypercalcaemia of malignancy. Oncologist 2000; 7: 481-491.
2. Peters R, Mishra V, Fraser WD. Severe hypocalcaemia after being given intravenous bisphosphonate. BMJ 2004; 328: 335-336.
3. Nowson CA, Margerison C. Vitamin D intake and vitamin D status of Australians. Med J Aust 2002; 177: 149-152. <MJA full text>

Online responses are no longer available. Please refer to our instructions for authors page for more information.